Table 1.
Summary of all included cases.
| Patient-No. | Age | Aneurysm localization | Neck width in mm | Dome width in mm | Dome height in mm | Implanted flow diverter | Proximal landing zone | Distal landing zone | Distance from FD to aneurysm in mm | OKM immediately after FD | OKM last available |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 1a | 57 | Left proximal PICA | 2.7 | 4.9 | 3.8 | FRED 4 × 12/18 mm | V4 proximal to the PICA | V4 distal to the PICA | 2.0 | A1 | A1 (no FU yet) |
| 2b | 72 | Right proximal AICA | 2 | 4.5 | 6.3 | Pipeline Flex Shield 4.75 × 14 mm | BA adjacent to V4 confluens | BA–middle third | 2.3 | A3 | A3 (no FU yet) |
| 3b | 75 | Left P1-P2-junction | 4.2 | 6.4 | 4.9 | FRED Jr. 2.5 × 13 mm | P1 segment | P2 segment | 1.5 | A3 | A1 (4 months & 5 months) |
| 4c | 53 | M2: superior trunk | 4 | 5.6 | 3.4 | P48MW_HPC 2 × 9 mm | Distal M1 segment | Proximal M3 segment | 1.0 | A2 | D1 (4 months) |
| 5d | 58 | Left proximal PICA | 4.2 | 4 | 3 | Surpass streamline 3 × 20 mm | V4 proximal to the PICA | V4 distal to the PICA | 2.0 | A1 | D1 (6months & 4years) |
| 6c | 43 | AcomA | 3.3 | 7 | 7 | Silk vista baby 2.5 × 15 mm | A1 | Proximal A2 | 2.4 | A3 | D1 (4 months) |
| 7e | 39 | MCA-M1 | 2.2 | 5.7 | 5 | PED3 vantage with shield technology 2.5 × 12 mm | Distal M1 | Distal M1 | 2.0 | B2 | B2 (no FU yet) |
| 8c | 63 | Right proximal A1 segment | 2.6 | 7.7 | 10.6 | Silk Vista Baby 2.75 × 15 mm | ICA communicating segment | Right M1 segment | 2.1 | A3 | D1 (3months) |
| 9c | 55 | Right posterior communicating artery | 1.3 | 1.9 | 1.3mm | Derivo 4.0 × 15 mm | ICA communicating segment | Right M1 segment | 1.6 | A3 | B3 (3months) |
| 10f | 68 | Left SUCA | 1.6 | 2.3 | 3.9 | PED 2 Shield 2.75 × 20 mm | BA: distal third | Left P1 segment | 1.1 | A2 | B3 (4months) |
| 11g | 63 | Right proximal PICA | 5.1 | 3.8 | 5.2 | FRED jr. 3.5 × 22 mm | V4 proximal to the PICA | V4 distal to the PICA | 2.1 | A2 | D1 (18 months) |
| 12g | 71 | Distal M1: origin of lateral fronto-orbital artery | 4.8 | 10.2 | 8.3 | FRED jr.3 × 19 mm | Middle M1 | Proximal M2 | 1.6 | A2 | D1 (6 months) |
| 13g | 70 | Left M2-M3-segment | 5 | 4.7 | 3.9 | Silk vista baby 2.75 × 15 mm | Inferior trunk: distal third | Parietal artery | 0.6 | A2 | D1 (16 months) |
| 14g | 66 | Right proximal AICA | 4.8 | 3.3 | 2.4 | Silk vista 4 × 15 mm | BA: proximal third | BA: middle third | 1.0 | A3 | D1 (4months) |
| 15g | 77 | Right M1-M2-segment | 6.7 | 10.7 | 6.7 | P48MW_HPC 3 × 15 mm | M1: middle third | M2: inferior trunk (dominant branch) | 2.4 | A2 | B2 (6 months) |
| 16g | 35 | Left proximal PICA | 4.3 | 9.2 | 4.5 | FRED X 4 × 18 mm | V4 proximal to the PICA | Distal V4 | 0.4 | A3 | A3 (no FU yet) |
| 17g | 63 | Right proximal A1 | 3 | 5.6 | 6.6 | Silk Vista 4 × 20 mm | Right C6 segment | Right M1 segment | 1.9 | B1 | B1 (no FU yet) |
Dual anti-platelet therapy:
9 months ASA 100 mg and Clopidogrel 75 mg daily, followed by ASA only lifelong.
4 months ASA 100 mg and Clopidogrel 75 mg daily, followed by ASA only lifelong.
6 months ASA 100 mg and Ticagrelor 90 mg twice a day, followed by ASA only lifelong.
4 months ASA 100 mg and Ticagrelor 90 mg twice a day, followed by ASA only lifelong.
12 months ASA 100 mg and Prasugrel 30 daily, followed by ASA lifelong.
6 months ASA 100 mg and Clopidogrel 75 mg daily, followed by ASA only lifelong.
3 months ASA 100 mg and Clopidogrel 75 mg, followed by ASA only lifelong.
Triaxial endovascular access in eleven cases (patients 1, 2, 4, 5, 6, 7, 8, 9, 10, 13, 14).
Guiding catheter: Neuron Max 088 (Penumbra) or the Benchmark 071 (Penumbra) or the Envoy 6F (Codman).
Distal access catheter: Sofia 5F (Microvention), Sofia EX (Microvention), CAT 5 (Stryker).
Biaxial endovascular access in six cases (patients 3, 11, 12, 15, 16, 17).
Guiding catheter: Envoy 6F or Envoy 7F (Codman).